SI

Shoulder Innovations, Inc.

14.25 USD
-0.80
5.32%
At close Aug 1, 4:00 PM EDT
After hours
14.79
+0.54
3.79%
1 day
-5.32%
5 days
-8.65%
1 month
-5.32%
3 months
-5.32%
6 months
-5.32%
Year to date
-5.32%
1 year
-5.32%
5 years
-5.32%
10 years
-5.32%
 

About: Shoulder Innovations Inc is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. It currently offers advanced implant systems for shoulder arthroplasty. Its products include: InSet Total Shoulder Arthroplasty; InSet Reverse Shoulder Arthroplasty; ProVoyance Shoulder Planning Software; and InSet Tray System.

Funds holding %
of 7,327 funds
Analysts bullish %

Fund manager confidence

Research analyst outlook

We haven’t received any recent analyst ratings for SI.

Financial journalist opinion

Based on 3 articles about SI published over the past 30 days

Positive
Seeking Alpha
1 day ago
Shoulder Innovations: Interesting, Not Convinced
Shoulder Innovations IPO priced below range, reflecting investor caution as revenue growth slows sharply despite strong prior expansion. Valuation is modest at 3-4x sales, supported by a substantial net cash position, but ongoing operating losses remain a concern. Key risks include product concentration, regulatory challenges, and fierce competition from established medtech giants like J&J and Stryker.
Shoulder Innovations: Interesting, Not Convinced
Positive
Seeking Alpha
3 weeks ago
U.S. IPO Weekly Recap: 6 Small Listings Hit Market As Sizable IPOs Join The Pipeline
Six IPOs and one SPAC debuted this week. Nine IPOs and two SPACs submitted initial filings this week. Two sizable mining companies are slated to go public in the US in the week ahead.
U.S. IPO Weekly Recap: 6 Small Listings Hit Market As Sizable IPOs Join The Pipeline
Negative
Seeking Alpha
3 weeks ago
Shoulder Innovations Begins IPO Effort For Commercialization Plans
Shoulder Innovations, Inc. has filed to raise $100 million in a U.S. IPO. The company is targeting the shoulder arthroplasty market, leveraging proprietary technology and a specialized commercial team, but faces intense competition and potential scaling risks. IPO proceeds will fund commercial expansion, R&D, and working capital, with management expecting funds to last at least 12 months post-offering.
Shoulder Innovations Begins IPO Effort For Commercialization Plans
Neutral
Business Wire
1 year ago
WorkForce Software Announces Partner Excellence Award Winners: Accenture, EPI-USE, Intelligenza IT, and SAP SuccessFactors, as Growing Demand for Workforce Management Technology and Global Expansion Continue in 2024
LIVONIA, Mich.--(BUSINESS WIRE)--WorkForce Software, a workforce management solution for large employers, announces the winners of its Partner Excellence Awards at VISION 2024.
WorkForce Software Announces Partner Excellence Award Winners: Accenture, EPI-USE, Intelligenza IT, and SAP SuccessFactors, as Growing Demand for Workforce Management Technology and Global Expansion Continue in 2024
Charts implemented using Lightweight Charts™